Literature DB >> 18535985

A role for VICKZ proteins in the progression of colorectal carcinomas: regulating lamellipodia formation.

G Vainer1, E Vainer-Mosse, A Pikarsky, S M Shenoy, F Oberman, A Yeffet, R H Singer, E Pikarsky, J K Yisraeli.   

Abstract

VICKZ proteins are a highly conserved family of RNA binding proteins, implicated in RNA regulatory processes such as intracellular RNA localization, RNA stability, and translational control. During embryogenesis, VICKZ proteins are required for neural crest migration and in adults, the proteins are overexpressed primarily in different cancers. We hypothesized that VICKZ proteins may play a role in cancer cell migration. In patients, VICKZ expression varies with tumour type, with over 60% of colon, lung, and ovarian tumours showing strong expression. In colorectal carcinomas (CRCs), expression is detected at early stages, and the frequency and intensity of staining increase with progression of the disease to lymph node metastases, of which 97% express the protein at high levels. Indeed, in stage II CRC, the level of VICKZ expression in the primary lesion correlates with the degree of lymph node metastasis. In culture, VICKZ proteins rapidly accumulate in processes at the leading edge of PMA-stimulated SW480 CRC cells, where they co-localize with beta-actin mRNA. Two distinct cocktails of shRNAs, each targeting all three VICKZ paralogues, cause a dramatic drop in lamellipodia and ruffle formation in stimulated cells. Thus, VICKZ proteins help to facilitate the dynamic cell surface morphology required for cell motility. We propose that these proteins play an important role in CRC metastasis by shuttling requisite RNAs to the lamellipodia of migrating cells. Copyright (c) 2008 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18535985      PMCID: PMC3148580          DOI: 10.1002/path.2376

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  50 in total

1.  RNA-binding protein conserved in both microtubule- and microfilament-based RNA localization.

Authors:  L Havin; A Git; Z Elisha; F Oberman; K Yaniv; S P Schwartz; N Standart; J K Yisraeli
Journal:  Genes Dev       Date:  1998-06-01       Impact factor: 11.361

2.  Antisense inhibition of beta-actin mRNA localization and its effect on smooth muscle cell migration.

Authors:  L Schedlich; M Hill; T Lockett
Journal:  Biol Cell       Date:  1997-05       Impact factor: 4.458

3.  Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein.

Authors:  F Müeller-Pillasch; U Lacher; C Wallrapp; A Micha; F Zimmerhackl; H Hameister; G Varga; H Friess; M Büchler; H G Beger; M R Vila; G Adler; T M Gress
Journal:  Oncogene       Date:  1997-06-05       Impact factor: 9.867

4.  Correlation of beta-actin messenger RNA localization with metastatic potential in rat adenocarcinoma cell lines.

Authors:  E A Shestakova; J Wyckoff; J Jones; R H Singer; J Condeelis
Journal:  Cancer Res       Date:  1999-03-15       Impact factor: 12.701

5.  Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors.

Authors:  Weigang Wang; Sumanta Goswami; Kyle Lapidus; Amber L Wells; Jeffrey B Wyckoff; Erik Sahai; Robert H Singer; Jeffrey E Segall; John S Condeelis
Journal:  Cancer Res       Date:  2004-12-01       Impact factor: 12.701

6.  Targeted knockdown of the RNA-binding protein CRD-BP promotes cell proliferation via an insulin-like growth factor II-dependent pathway in human K562 leukemia cells.

Authors:  Baisong Liao; Meera Patel; Yan Hu; Sandy Charles; David J Herrick; Gary Brewer
Journal:  J Biol Chem       Date:  2004-09-08       Impact factor: 5.157

7.  Protein translation components are colocalized in granules in oligodendrocytes.

Authors:  E Barbarese; D E Koppel; M P Deutscher; C L Smith; K Ainger; F Morgan; J H Carson
Journal:  J Cell Sci       Date:  1995-08       Impact factor: 5.285

8.  beta-Actin messenger RNA localization and protein synthesis augment cell motility.

Authors:  E H Kislauskis; X Zhu; R H Singer
Journal:  J Cell Biol       Date:  1997-03-24       Impact factor: 10.539

9.  A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma.

Authors:  J Y Zhang; E K Chan; X X Peng; E M Tan
Journal:  J Exp Med       Date:  1999-04-05       Impact factor: 14.307

10.  Serum-induced signal transduction determines the peripheral location of beta-actin mRNA within the cell.

Authors:  M A Hill; L Schedlich; P Gunning
Journal:  J Cell Biol       Date:  1994-09       Impact factor: 10.539

View more
  26 in total

1.  XPO1/CRM1 Inhibition Causes Antitumor Effects by Mitochondrial Accumulation of eIF5A.

Authors:  Takahito Miyake; Sunila Pradeep; Sherry Y Wu; Rajesha Rupaimoole; Behrouz Zand; Yunfei Wen; Kshipra M Gharpure; Archana S Nagaraja; Wei Hu; Min Soon Cho; Heather J Dalton; Rebecca A Previs; Morgan L Taylor; Takeshi Hisamatsu; Yu Kang; Tao Liu; Sharon Shacham; Dilara McCauley; David H Hawke; John E Wiktorowicz; Robert L Coleman; Anil K Sood
Journal:  Clin Cancer Res       Date:  2015-04-15       Impact factor: 12.531

2.  IGF2BP1 promotes cell migration by regulating MK5 and PTEN signaling.

Authors:  Nadine Stöhr; Marcel Köhn; Marcell Lederer; Markus Glass; Claudia Reinke; Robert H Singer; Stefan Hüttelmaier
Journal:  Genes Dev       Date:  2012-01-15       Impact factor: 11.361

3.  IMP1 3' UTR shortening enhances metastatic burden in colorectal cancer.

Authors:  Sarah F Andres; Kathy N Williams; Jacqueline B Plesset; Jeffrey J Headd; Rei Mizuno; Priya Chatterji; Ashley A Lento; Andres J Klein-Szanto; Rosemarie Mick; Kathryn E Hamilton; Anil K Rustgi
Journal:  Carcinogenesis       Date:  2019-06-10       Impact factor: 4.944

Review 4.  Control of cell migration through mRNA localization and local translation.

Authors:  Guoning Liao; Lisa Mingle; Livingston Van De Water; Gang Liu
Journal:  Wiley Interdiscip Rev RNA       Date:  2014-09-28       Impact factor: 9.957

5.  miR-625 suppresses tumour migration and invasion by targeting IGF2BP1 in hepatocellular carcinoma.

Authors:  X Zhou; C Z Zhang; S-X Lu; G G Chen; L-Z Li; L-L Liu; C Yi; J Fu; W Hu; J-M Wen; J-P Yun
Journal:  Oncogene       Date:  2014-03-17       Impact factor: 9.867

Review 6.  Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis.

Authors:  Weihong Liu; Bo Peng; Yumin Lu; Weijia Xu; Wei Qian; Jian-Ying Zhang
Journal:  Autoimmun Rev       Date:  2010-12-15       Impact factor: 9.754

7.  MicroRNA-873 (miRNA-873) inhibits glioblastoma tumorigenesis and metastasis by suppressing the expression of IGF2BP1.

Authors:  Ren-jie Wang; Jian-wei Li; Bu-he Bao; Huan-cheng Wu; Zhen-hua Du; Jing-liang Su; Ming-hua Zhang; Hai-qian Liang
Journal:  J Biol Chem       Date:  2015-02-10       Impact factor: 5.157

8.  Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival.

Authors:  David F Schaeffer; Daniel R Owen; Howard J Lim; Andrew K Buczkowski; Stephen W Chung; Charles H Scudamore; David G Huntsman; Sylvia S W Ng; David A Owen
Journal:  BMC Cancer       Date:  2010-02-23       Impact factor: 4.430

9.  IMP1 promotes tumor growth, dissemination and a tumor-initiating cell phenotype in colorectal cancer cell xenografts.

Authors:  Kathryn E Hamilton; Felicite K Noubissi; Prateek S Katti; Christopher M Hahn; Sonya R Davey; Emma T Lundsmith; Andres J Klein-Szanto; Andrew D Rhim; Vladimir S Spiegelman; Anil K Rustgi
Journal:  Carcinogenesis       Date:  2013-06-12       Impact factor: 4.944

10.  β-Actin mRNA compartmentalization enhances focal adhesion stability and directs cell migration.

Authors:  Zachary B Katz; Amber L Wells; Hye Yoon Park; Bin Wu; Shailesh M Shenoy; Robert H Singer
Journal:  Genes Dev       Date:  2012-09-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.